Steven A. Rosenberg

Steven Rosenberg is widely regarded as the father of modern cancer immunotherapy. His laboratory at the National Cancer Institute pioneered the use of tumor-infiltrating lymphocytes (TILs) for cancer treatment, demonstrating durable complete responses in metastatic melanoma. Rosenberg's work laid the foundation for all adoptive cell therapies including CAR-T cells, and he continues to advance personalized cancer immunotherapy approaches.

Steven Rosenberg被广泛认为是现代癌症免疫治疗之父。他在美国国家癌症研究所的实验室开创了使用肿瘤浸润淋巴细胞（TIL）治疗癌症的方法，在转移性黑色素瘤中展示了持久的完全缓解。Rosenberg的工作为包括CAR-T细胞在内的所有过继细胞治疗奠定了基础，他继续推进个性化癌症免疫治疗方法。